Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis

Publisher Name :
Date: 8-Apr-2013
No. of pages: 158

Global Molecular Diagnostics Market & Future Forecast to 2017 Overview

The global molecular diagnostics market is witnessing a period of profound growth. The growth is coming from different regions and markets. The next five years will witness significant developments in molecular diagnostics such as automation, as well as introduction of a wide range of new products. Molecular Diagnostics involves multiple technologies to identify genetic variations in individual patients. These technologies include PCR, FISH, hybrid capture, sequencing and microarrays. The increase in the aging population and incidences of various chronic diseases are driving the demand of molecular diagnostics world over. The industry is getting a push from every side and many factors collectively are fuelling the growth in this industry. Growing with a CAGR of 14.64 percent global molecular diagnostics market is expected to double its market size in 2017 from the market of 2012.

Molecular Diagnostics Market – Application Segment Analysis

•    The infectious disease testing is the leading application in Molecular Diagnostic. It is likely to hold XXXX% share in 2017.
•    Molecular oncology tests have emerged as a second significant rapidly growing market segment. Genetic Testing and Blood Screening are at the third and fourth spot respectively in 2012.
•    The cardiovascular disease testing and neurological testing are closely competing with each other to gain the maximum market share.
•    Food testing market is expected to inch up to US$ XXXX Million in 2017.
Technologies Segment Analysis
•    Biochips and PCR based test accounts for the largest shares in the molecular diagnostics technologies segment with XXXX% and XXXX% respectively in 2012.
•    Fish & Innovations technology market is at the 3rd slot.
•    The PCR related technologies and Non- PCR market is at the 4th and 5th position respectively.
•    The biosensor and Molecular Imaging technology are also showing impressive growth.
Geographical Analysis
•    United States molecular diagnostic market is expected to be more than double by 2017 from its current market in 2012.
•    Europe stands at the second position in the global molecular diagnostic market.
•    China, Japan and India are expected to stand at 3rd, 4th and 5th slot respectively.
•    The Mexico molecular diagnostics market is predicted to grow at a CAGR of 17% between 2012 and 2017.
Company Wise Analysis
•    The Roche molecular diagnostic share is greater than the combined share of Myriad Genetics and Qiagen which holds the 2nd and 3rd position respectively.
•    Abbott stands at the 4th spot and expected to generate sales worth US$ XXXX Million by the year 2017.
•    The Myriad Genetics molecular diagnostic sales were worth US$ XXXX Million in 2012.

Renub Research study titled “Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis” provides a comprehensive assessment of the fast-evolving, high-growth Global Molecular Diagnostics market. This 158 page report with 81 Figures and 23 Tables studies the Global Molecular Diagnostics: 1) Market and Forecast 2) Application Wise Market & Forecast 3) Geographical Market & Forecast 4) Technology Wise Market & Forecast 5) Company Wise molecular Diagnostics sales & Forecast 6) Molecular Diagnostic & Personalized Medicines 7) Clinical trials In Molecular Diagnostics Landscape.

The Report Covers the Following Points
•    Global Molecular Diagnostic Market (2010-12) and Forecast (2013 to 2017)
•    Global Molecular Diagnostic Application Segment (Infectious Disease Testing, Virology Testing, HAI Testing, HPV Testing, Critical Care Infectious Testing, Blood Screening, Genetic Testing, Oncology Testing, Tissue Typing, Cardiovascular Disease Testing, Neurological Disorders Testing, Food Pathogen Detection Testing & Others) Market (2010-2012) and Forecast (2013 to 2017)
•    Molecular Diagnostic Technology Segment (PCR Based Test, PCR Related Technologies , Non-PCR Test, Fish & Innovations Testing, Biochips/Microarrays, Biosensors, Molecular Imaging, & Other Technologies) Market (2010-2012) and Forecast (2013 to 2017)
•    Molecular Diagnostic Geographical Distribution (US, Europe, China, Japan, India, Brazil, Mexico, South Korea and Rest of World) Market (2010-2012) and Forecast (2013 to 2017)
•    Molecular Diagnostic Sales Company Wise Analysis (Roche, Abbott, Myriad Genetics, Qiagen, BioMérieux and Others ) Market (2010-2012) and Forecast (2013 to 2017)
•    Molecular Diagnostic and Road to Personalized medicine
•    Molecular Diagnostic Clinical Trial Statements (20 Clinical Trials Studied in the report)
•    Driving Forces & Challenges for Global Molecular Diagnostic Market

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.

Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis

Table of Contents

1. Executive Summary

2. Molecular Diagnostics Market & Forecast - (2010 - 2017)

3. Molecular Diagnostics Market Share - (2010 - 2017)
3.1 Share & Forecast - Application Wise
3.2 Share & Forecast - Technology Wise
3.3 Share & Forecast - Region Wise
3.4 Share & Forecast - Company Wise

4. Molecular Diagnostics Market (Application Segment) - (2010 - 2017)
4.1 Infectious Disease Testing Market & Forecast
4.1.1 Virology (HIV, HCV, HBV) Testing Market & Forecast
4.1.2 Health - Associated Infections (HAI) Testing Market & Forecast
4.1.3 HPV Testing Market & Forecast
4.1.4 Critical Care Infectious Testing Market & Forecast
4.2 Blood Screening Market & Forecast
4.3 Genetic Testing Market & Forecast
4.4 Oncology Testing Market & Forecast
4.5 Tissue Typing (HLA Testing) Market & Forecast
4.6 Cardiovascular Disease Testing Market & Forecast
4.7 Neurological Disorders Testing Market & Forecast
4.8 Food Pathogen Detection Testing Market & Forecast
4.9 Miscellaneous Testing Market & Forecast

5. Molecular Diagnostics Market (Technologies Segment) - (2010 - 2017)
5.1 PCR Based Test Market & Forecast
5.2 PCR Related Technologies Market & Forecast
5.3 Non-PCR Test Market & Forecast
5.4 Fish & Innovations Testing Market (Fluorescent in-situ hybridization) & Forecast
5.5 Biochips/Microarrays Market & Forecast
5.6 Biosensors Market & Forecast
5.7 Molecular Imaging Market & Forecast
5.8 Other Technologies Market & Forecast

6. Geographical Distribution - Molecular Diagnostics Market - (2008 - 2017)
6.1 United States Molecular Diagnostics Market & Forecast
6.2 Europe Molecular Diagnostics Market & Forecast
6.3 China Molecular Diagnostics Market & Forecast
6.4 Japan Molecular Diagnostics Market & Forecast
6.5 India Molecular Diagnostics Market & Forecast
6.6 Brazil Molecular Diagnostics Market & Forecast
6.7 Mexico Molecular Diagnostics Market & Forecast
6.8 South Korea Molecular Diagnostics Market & Forecast
6.9 Rest of World Molecular Diagnostics Market & Forecast

7. Molecular Diagnostics Market (Company Wise) - (2010 - 2017)
7.1 Roche Molecular Diagnostics Market & Forecast
7.2 Abbott Molecular Diagnostics Market & Forecast
7.3 Myriad Genetics Molecular Diagnostics Market & Forecast
7.4 Qiagen Molecular Diagnostics Market & Forecast
7.5 BioMérieux Molecular Diagnostics Market & Forecast
7.6 Other Companies Molecular Diagnostics Market & Forecast

8. Molecular Diagnostics and Personalized Medicine
8.1 Road to Personalized Medicine
8.1.1 Historical perspective: HIV & Oncology
8.1.2 Other Applications: Met & Unmet Therapy Areas
8.2 Molecular Diagnostics Technologies
8.2.1 Expression Profiling - RNA & Pharmacogenomics
8.2.2 Expression Profiling - Proteins & Pharmacoproteomics
8.2.3 DNA Sequence Profiling - Pharmacogenetic & SNP Analysis
8.2.4 DNA Sequence Profiling - High-Throughput Sequencing
8.3 Molecular Diagnostics and Personalized Medicine: Value-Assessed Opportunities for Multiple Stakeholders Values, Needs & Expectations
8.4 Regulatory Authorities
8.5 Molecular Diagnostics as Companion Diagnostics: Value-Driven Adoption
8.5.1 Behavioral Impact
8.5.2 Economic Impact (Value-Based vs. Cost-Plus Pricing)

9. Molecular Diagnostics Clinical Trial Statement
9.1 Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples
9.2 Crizotinib Efficacy In Non-Small Cell Lung Cancer Patients With Anaplastic Lymphoma Kinase (ALK) Translocation
9.3 A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus
9.4 Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
9.5 A Two Arm, Multi-Centre Clinical Evaluation of the xTAG Respiratory Viral Panel v3 Test
9.6 Collecting and Storing Tissue Samples from Patients with Rare or Cutaneous Non-Hodgkin Lymphoma
9.7 Biopsies of Cancer Patients for Tumor Molecular Characterization
9.8 Daptomycin versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia
9.9 Collection of Tissue Samples for Cancer Research
9.10 Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
9.11 Total Therapy Study XVI for Newly Diagnosed Patients with Acute Lymphoblastic Leukemia
9.12 Tumor Genomic Profiling in Patients Evaluated for Targeted Cancer Therapy
9.13 Congenital Muscle Disease Study of Patient and Family Reported Medical Information
9.14 Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer from Fine Needle Aspirates
9.15 Extending Molecular Responses with Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients in Chronic Phase
9.16 CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
9.17 Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
9.18 Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
9.19 Radotinib versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients
9.20 Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)

10. Molecular Diagnostics Market - Drivers
10.1 Various Developments in the Molecular Diagnostics Landscape
10.2 Increasing Investment in Genomics & Proteomics Research
10.3 Technological Advances in Molecular Diagnostics
10.4 Increasing Acceptance of the Personalized Medicine
10.5 Growing Molecular Diagnostics for Food Safety

11. Molecular Diagnostics Market - Challenges
11.1 Regulatory Issues
11.2 Various Factors Slowing Growth of Molecular Diagnostics
11.3 Reimbursement Capabilities
11.4 Quality Checkpoints, Awareness & Acceptance

List of Tables
Table 3 1: Global Molecular Diagnostics - Company Wise Market Share (Percent), 2010 - 2012
Table 3 2: Global Molecular Diagnostics - Forecast for Company Wise Market Share (Percent), 2013 - 2017
Table 8 1: Molecular Platforms for Companion Diagnostics
Table 9 1: Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples - Clinical Trials, 2012
Table 9 2: Crizotinib Efficacy in Non-Small Cell Lung Cancer Patients with Anaplastic Lymphoma Kinase Translocation - Clinical Trials, 2012
Table 9 3: A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus - Clinical Trials, 2012
Table 9 4: Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler - Clinical Trials, 2012
Table 9 5: A Two Arm, Multi-Centre Clinical Evaluation of the xTAG Respiratory Viral Panel v3 Test - Clinical Trials, 2013
Table 9 6: Collecting and Storing Tissue Samples from Patients with Rare or Cutaneous Non-Hodgkin Lymphoma - Clinical Trials, 2012
Table 9 7: Biopsies of Cancer Patients for Tumor Molecular Characterization - Clinical Trails, 2012
Table 9 8: Daptomycin versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia - Clinical Trials, 2013
Table 9 9: Collection of Tissue Samples for Cancer Research - Clinical Trials, 2012
Table 9 10: Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma - Clinical Trials, 2012
Table 9 11: Total Therapy Study XVI for Newly Diagnosed Patients with Acute Lymphoblastic Leukemia - Clinical Trials, 2012
Table 9 12: Tumor Genomic Profiling in Patients Evaluated for Targeted Cancer Therapy, 2013
Table 9 13: Congenital Muscle Disease Study of Patient and Family Reported Medical Information - Clinical Trials, 2013
Table 9 14: Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer from Fine Needle Aspirates - Clinical Trials, 2013
Table 9 15: Extending Molecular Responses with Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients in Chronic Phase - Clinical Trials, 2012
Table 9 16: CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib - Clinical Trial, 2013
Table 9 17: Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile - Clinical Trials, 2013
Table 9 18: Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients - Clinical Trials, 2012
Table 9 19: Radotinib versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients - Clinical Trials, 2012
Table 9 20: Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG) - Clinical Trials, 2012

List of Figures
Figure 2 1: Global - Molecular Diagnostics Market (Million US$), 2010 - 2012
Figure 2 2: Global - Forecast for Molecular Diagnostics Industry (Million US$), 2013 - 2017
Figure 3 1: Global Molecular Diagnostics - Application Wise Market Share (Percent), 2010 - 2012
Figure 3 2: Global Molecular Diagnostics - Forecast for Application Wise Market Share (Percent), 2013 - 2017
Figure 3 3: Global Molecular Diagnostics - Technology Wise Market Share (Percent), 2010 - 2012
Figure 3 4: Global Molecular Diagnostics - Forecast for Technology Wise Market Share (Percent), 2013 - 2017
Figure 3 5: Global Molecular Diagnostics - Region Wise Market Share (Percent), 2010 - 2012
Figure 3 6: Global Molecular Diagnostics - Forecast for Region Wise Market Share (Percent), 2013 - 2017
Figure 4 1: Global - Infectious Disease Testing Market (Million US$), 2010 - 2012
Figure 4 2: Global - Forecast for Infectious Disease Testing Market (Million US$), 2013 - 2017
Figure 4 3: Global - Virology Testing Market (Million US$), 2010 - 2012
Figure 4 4: Global - Forecast for Virology Testing Market (Million US$), 2013 - 2017
Figure 4 5: Global - HAI Testing Market (Million US$), 2010 - 2012
Figure 4 6: Global - Forecast for HAI Testing Market (Million US$), 2013 - 2017
Figure 4 7: Global - HPV Testing Market (Million US$), 2010 - 2012
Figure 4 8: Global - Forecast for HPV Testing Market (Million US$), 2013 - 2017
Figure 4 9: Global - Critical Care Infectious Testing Market (Million US$), 2008 - 2012
Figure 4 10: Global - Forecast for Critical Care Infectious Testing Market (Million US$), 2013 - 2017
Figure 4 11: Global - Blood Screening Market (Million US$), 2007 - 2012
Figure 4 12: Global - Forecast for Blood Screening Market (Million US$), 2013 - 2017
Figure 4 13: Global - Genetic Testing Market (Million US$), 2010 - 2012
Figure 4 14: Global - Forecast for Genetic Testing Market (Million US$), 2013 - 2017
Figure 4 15: Global - Oncology Market (Million US$), 2010 - 2012
Figure 4 16: Global - Forecast for Oncology Market (Million US$), 2013 - 2017
Figure 4 17: Global - Tissue Typing Market (Million US$), 2008 - 2012
Figure 4 18: Global - Forecast for Tissue Typing Market (Million US$), 2013 - 2017
Figure 4 19: Global - Cardiovascular Disease Testing Market (Million US$), 2010 - 2012
Figure 4 20: Global - Forecast for Cardiovascular Disease Testing Market (Million US$), 2013 - 2017
Figure 4 21: Global - Neurological Disorders Testing Market (Million US$), 2010 - 2012
Figure 4 22: Global - Forecast for Neurological Disorders Testing Market (Million US$), 2013 - 2017
Figure 4 23: Global - Food Pathogen Detection Testing Market (Million US$), 2010 - 2012
Figure 4 24: Global - Forecast for Food Pathogen Detection Testing Market (Million US$), 2013 - 2017
Figure 4 25: Global - Miscellaneous Testing Market (Million US$), 2010 - 2012
Figure 4 26: Global - Forecast for Miscellaneous Testing Market (Million US$), 2013 - 2017
Figure 5 1: Global - PCR Based Test Market (Million US$), 2010 - 2012
Figure 5 2: Global - Forecast for PCR Based Test Market (Million US$), 2013 - 2017
Figure 5 3: Global - PCR Related Technologies Market (Million US$), 2010 - 2012
Figure 5 4: Global - Forecast for PCR Related Technologies Market (Million US$), 2013 - 2017
Figure 5 5: Global - Non-PCR Test Market (Million US$), 2010 - 2012
Figure 5 6: Global - Forecast for Non-PCR Test Market (Million US$), 2013 - 2017
Figure 5 7: Global - Fish & Innovations Market (Million US$), 2010 - 2012
Figure 5 8: Global - Forecast for Fish & Innovations Market (Million US$), 2013 - 2017
Figure 5 9: Global - Biochips/ Microarrays Market (Million US$), 2010 - 2012
Figure 5 10: Global - Forecast for Biochips/Micrroarrays Market (Million US$), 2013 - 2017
Figure 5 11: Global - Biosensors Market (Million US$), 2010 - 2012
Figure 5 12: Global - Forecast for Biosensors Market (Million US$), 2013 - 2017
Figure 5 13: Global - Molecular Imaging Market (Million US$), 2010 - 2012
Figure 5 14: Global - Forecast for Molecular Imaging Market (Million US$), 2013 - 2017
Figure 5 15: Global - Other Technologies Market (Million US$), 2010 - 2012
Figure 5 16: Global - Forecast for Other Technologies Market (Million US$), 2012 - 2017
Figure 6 1: US - Molecular Diagnostics Market (Million US$), 2002 - 2012
Figure 6 2: US - Forecast for Molecular Diagnostics Market (Million US$), 2013 - 2017
Figure 6 3: Europe - Molecular Diagnostics Market (Million US$), 2010 - 2012
Figure 6 4: Europe - Forecast for Molecular Diagnostics Market (Million US$), 2013 - 2017
Figure 6 5: China - Molecular Diagnostics Market (Million US$), 2010 - 2012
Figure 6 6: China - Forecast for Molecular Diagnostics Market (Million US$), 2013 - 2017
Figure 6 7: Japan - Molecular Diagnostics Market (Million US$), 2010 - 2012
Figure 6 8: Japan - Forecast for Molecular Diagnostics  Industry (Million US$), 2013 - 2017
Figure 6 9: India - Molecular Diagnostics Market (Million US$), 2010 - 2012
Figure 6 10: India - Forecast for Molecular Diagnostics  Industry (Million US$), 2013 - 2017
Figure 6 11: Brazil - Molecular Diagnostics Market (Million US$), 2007 - 2012
Figure 6 12: Brazil - Forecast for Molecular Diagnostics  Industry (Million US$), 2013 - 2017
Figure 6 13: Mexico - Molecular Diagnostics Market (Million US$), 2007 - 2012
Figure 6 14: Mexico - Forecast for Molecular Diagnostics  Industry (Million US$), 2013 - 2017
Figure 6 15: South Korea - Molecular Diagnostics Market (Million US$), 2005 - 2012
Figure 6 16: South Korea - Forecast for Molecular Diagnostics  Industry (Million US$), 2013 - 2017
Figure 6 17: Rest of World - Molecular Diagnostics Market (Million US$), 2010 - 2012
Figure 6 18: Rest of World - Forecast for Molecular Diagnostics  Industry (Million US$), 2013 - 2017
Figure 7 1: Roche - Molecular Diagnostics Sales (Million US$), 2008 - 2012
Figure 7 2: Roche - Forecast for Molecular Diagnostics Sales (Million US$), 2013 - 2017
Figure 7 3: Abbott - Molecular Diagnostics Sales (Million US$), 2010 - 2012
Figure 7 4: Abbott - Forecast for Molecular Diagnostics Sales (Million US$), 2013 - 2017
Figure 7 5: Myriad Genetics - Molecular Diagnostics Sales (Million US$), 2007 - 2012
Figure 7 6: Myriad Genetics - Forecast for Molecular Diagnostics Sales (Million US$), 2013 - 2017
Figure 7 7: Qiagen - Molecular Diagnostics Sales (Million US$), 2009 - 2012
Figure 7 8: Qiagen - Forecast for Molecular Diagnostics Sales (Million US$), 2013 - 2017
Figure 7 9: BioMérieux - Molecular Diagnostics Sales (Million US$), 2010 - 2012
Figure 7 10: BioMérieux - Forecast for Molecular Diagnostics Sales (Million US$), 2013 - 2017
Figure 7 11: Other Companies - Molecular Diagnostics Sales (Million US$), 2010 - 2012
Figure 7 12: Other Companies - Forecast for Molecular Diagnostics Sales (Million US$), 2013 - 2017
Figure 8 1: A Healthcare ‘Value-Net

 

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Surgical Imaging Market by Product (Mobile C-arm/ Mini C-arm) & by Application (Orthopedic and Trauma/Neurosurgery/Cardiovascular/Hand and Wrist/ Foot and Ankle/ Pediatric) – Competitive Landscape, Global Forecasts & Trends to 2019
    Published: 22-Oct-2014        Price: US $4650 Onwards        Pages: 132
    The global surgical imaging market was valued at an estimated $933.6 million in 2014 and is expected to grow at a CAGR of 6.0% from 2014 to 2019. North America accounted for the largest share of the global surgical imaging market followed by Europe and Asiavalued at $378.6 million in 2014.The dominance of the North American market can be attributed to reasons such as the increasing prevalence of sports injuries in this region as well as the availability of private and government funding for t......
  • Global Coagulation Testing Market 2014-2018
    Published: 22-Oct-2014        Price: US $2500 Onwards        Pages: 72
    Coagulation tests help in measuring the clotting ability of blood. Clotting is the process of blood converting from liquid into gel form. Coagulation tests are performed to analyze clotting disorders such as hemorrhage and thrombosis. Coagulation tests include complete blood count, factor V assay, fibrinogen level, prothrombin time, platelet count, thrombin time, and bleeding time. Coagulation testing analyzers play a major role in improving patients' quality of life. TechNavio's analysts for......
  • Global Drug Abuse Testing Market 2014-2018
    Published: 22-Oct-2014        Price: US $2500 Onwards        Pages: 75
    Drugs are chemical substances, which are generally used in the diagnosis, treatment, and prevention of diseases. Drugs when used as medicines have positive effects on patients; however, some people use drugs for non-medical purposes, which leads to serious health problems. Drug abuse testing is a technical analysis of biological specimen to determine the drugs or combination of drugs consumed by a person. The biological specimens used for the test are saliva, urine, blood, hair, breath, and swea......
  • Global Preimplantation Genetic Diagnosis (PGD) Market 2014-2018
    Published: 22-Oct-2014        Price: US $2500 Onwards        Pages: 52
    Preimplantation genetic diagnosis (PGD) testing involves the identification of genetic defects in embryos. It is performed to identify single gene disorders such as Sickle Cell Anemia, Cystic Fibrosis, Huntington's Disease, Hemophilia, Marfan's Disease, Thalassemia, Muscular Dystrophy, Tay Sachs, and Spinal Muscular Atrophy. PGD tests are generally carried out in cases of a known genetic defect, or in late age pregnancy, or in patients with a history of repeated miscarriages. PCR, FISH, CGH, and......
  • China Independent Clinical Laboratory Industry Report, 2014-2017
    Published: 21-Oct-2014        Price: US $1850 Onwards        Pages: 78
    The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there was around RMB3.5 billion, up as much as 70% yr-on-yr, yet only accounting for 2%-3% of the total revenue of medical diagnosis. There are about 110 independent clinical laboratories in today’s China, but most of them are small sized. KingMed Diagnostics, ADICON, DIAN Diagnostics and DAAN Gene ......
  • Optical Imaging Market by Technique (Optical Coherence Tomography, Hyperspectral Imaging, Photoacoustic Tomography), Product (Imaging System, Imaging software) & by Application (Ophthalmology, Neurology, Oncology, Cardiology) – Global Forecasts to 2019
    Published: 17-Oct-2014        Price: US $4650 Onwards        Pages: 225
    Over the last decade, the optical imaging market has grown, primarily due to the widening applications of optical imaging techniques, the increased demand for safer and noninvasive imaging modalities, and a rising need to minimize the use of radiation in diagnostic imaging. The fast-growing pharmaceutical and biotechnology industries are also catalyzing the growth of the optical imaging market. In this report, the global optical imaging market is segmented by techniques, products, application......
  • Global Digital Pathology Market 2014-2018
    Published: 15-Oct-2014        Price: US $2500 Onwards        Pages: 80
    Digital pathology includes managing, interpreting, and analysing the digital information. It also termed as virtual microscopy or virtual pathology. It includes the process of developing glass images and then converting to digital slides with the digital solutions. Digital pathology is used by many users such as forensic pathology, oral pathology, human pathology, and veterinary pathology. The increased benefits of the digital pathology is driving the market. Digital pathology has changed the wa......
  • Picture Archiving and Communication Systems Market to 2020 – Digitization of Healthcare Systems and Evolution of PACS as a Decision Support Tool Drive Growth
    Published: 1-Oct-2014        Price: US $3500 Onwards        Pages: 68
    GBI Research’s report, “Picture Archiving and Communication Systems Market to 2020 - Digitization of Healthcare Systems and Evolution of PACS as a Decision Support Tool Drive Growth” discusses the market, competitive landscape, and trends for two Picture Archiving and Communications Systems (PACS) market segments: radiology PACS and cardiology PACS. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the dynamics of the overall ma......
  • Global Database of the Top 1000 Analytical Laboratory Instrument Producers – Company Names, Financial Performance, Key Executives, and Contact Details
    Published: 1-Oct-2014        Price: US $1275 Onwards        
    This company database offers valuable information on top 1000 analytical laboratory instrument producers in the world which makes the database an invaluable resource for industry executives, marketing, sales and product managers, analysts, and other people looking for key company information in readily accessible and clearly presented format. The database is essential for companies who want to find out more about the leading players on the market or to find and contact potential customers and pa......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs